Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells

Cancer Letters

Volumn 247, Issue 2, 2007, Pages 273-282

  Casado, Pedro ^a   Zuazua Villar, Pedro ^a   Valle, Eva del ^a   Martínez Campa, Carlos ^a   Lazo, Pedro S ^a   Ramos, Sofía ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

2D PAGE; Breast cancer; HSP27; MALDI TOF MS; Phosphorylation; Vincristine

Indexed keywords

ANTIBODY; MESSENGER RNA; PHOSPHOPROTEIN; SERINE; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; UPREGULATION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; SERINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VINCRISTINE;

EID: 33846940789     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.05.005     Document Type: Article

References (34)

1. Jordan M.A., and Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10 (1998) 123-130
2. Noble R.L. The discovery of the vinca alkaloids - chemotherapeutic agents against cancer. Biochem. Cell Biol. 68 (1990) 1344-1351
3. Toso C., and Lindley C. Vinorelbine: a novel vinca alkaloid. Am. J. Health Syst. Pharm. 52 (1995) 1287-1304 quizz 1340-1341
4. Owellen R.J., Root M.A., and Hains F.O. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 37 (1977) 2603-2607
5. Gigant B., Wang C., Ravelli R.B., Roussi F., Steinmetz M.O., Curmi P.A., Sobel A., and Knossow M. Structural basis for the regulation of tubulin by vinblastine. Nature 435 (2005) 519-522
6. Wang T.H., Wang H.S., Ichijo H., Giannakakou P., Foster J.S., Fojo T., and Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273 (1998) 4928-4936
7. Ruvolo P.P., Deng X., and May W.S. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15 (2001) 515-522
8. Kavallaris M., Tait A.S., Walsh B.J., He L., Horwitz S.B., Norris M.D., and Haber M. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res. 61 (2001) 5803-5809
9. Sirotnak F.M., Danenberg K.D., Chen J., Fritz F., and Danenberg P.V. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms. Biochem. Biophys. Res. Commun. 269 (2000) 21-24
10. Verrills N.M., Walsh B.J., Cobon G.S., Hains P.G., and Kavallaris M. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J. Biol. Chem. 278 (2003) 45082-45093
11. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002) 48-58
12. Stow M.W., and Warr J.R. Reduced influx is a factor in accounting for reduced vincristine accumulation in certain verapamil-hypersensitive multidrug-resistant CHO cell lines. FEBS Lett. 320 (1993) 87-91
13. Yao D., Ding S., Burchell B., Wolf C.R., and Friedberg T. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance. J. Pharmacol. Exp. Ther. 294 (2000) 387-395
14. Huot J., Roy G., Lambert H., Chretien P., and Landry J. Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res. 51 (1991) 5245-5252
15. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., Gurbuxani S., Arrigo A.P., Kroemer G., Solary E., and Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2 (2000) 645-652
16. Paul C., Manero F., Gonin S., Kretz-Remy C., Virot S., and Arrigo A.P. Hsp27 as a negative regulator of cytochrome C release. Mol. Cell. Biol. 22 (2002) 816-834
17. Charette S.J., Lavoie J.N., Lambert H., and Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol. Cell. Biol. 20 (2000) 7602-7612
18. Lavoie J.N., Lambert H., Hickey E., Weber L.A., and Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol. 15 (1995) 505-516
19. Mehlen P., Kretz-Remy C., Preville X., and Arrigo A.P. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J. 15 (1996) 2695-2706
20. Rogalla T., Ehrnsperger M., Preville X., Kotlyarov A., Lutsch G., Ducasse C., Paul C., Wieske M., Arrigo A.P., Buchner J., and Gaestel M. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J. Biol. Chem. 274 (1999) 18947-18956
21. Kato K., Hasegawa K., Goto S., and Inaguma Y. Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. J. Biol. Chem. 269 (1994) 11274-11278
22. M. Tuloup, C. Hernandez, I. Coro, C. Hoogland, P.-A. Binz, R.D. Appel, Aldente and BioGraph: An improved peptide mass fingerprinting protein identification environment, Swiss Proteomics Society 2003 Congress: Understanding Biological Systems through Proteomics. ISBN 2-88476-004-0 (2003) 174-176.
23. Jordan M.A., Himes R.H., and Wilson L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res. 45 (1985) 2741-2747
24. Martinez-Campa C., Casado P., Rodriguez R., Zuazua P., Garcia-Pedrero J.M., Lazo P.S., and Ramos S. Effect of Vinca alkaloids on ERalpha levels and Estradiol-induced responses in MCF-7 cells. Breast Cancer Res. Treat. (2006)
25. Schepers H., Geugien M., van der Toorn M., Bryantsev A.L., Kampinga H.H., Eggen B.J., and Vellenga E. HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun. Exp. Hematol. 33 (2005) 660-670
26. Lambert H., Charette S.J., Bernier A.F., Guimond A., and Landry J. HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J. Biol. Chem. 274 (1999) 9378-9385
27. Conroy S.E., and Latchman D.S. Do heat shock proteins have a role in breast cancer?. Br. J. Cancer 74 (1996) 717-721
28. Bruey J.M., Paul C., Fromentin A., Hilpert S., Arrigo A.P., Solary E., and Garrido C. Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene 19 (2000) 4855-4863
29. Garrido C., Ottavi P., Fromentin A., Hammann A., Arrigo A.P., Chauffert B., and Mehlen P. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res. 57 (1997) 2661-2667
30. Micheau O., Solary E., Hammann A., and Dimanche-Boitrel M.T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274 (1999) 7987-7992
31. Park K.J., Gaynor R.B., and Kwak Y.T. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappaB activation. J. Biol. Chem. 278 (2003) 5272-5278
32. Huang Y., Fang Y., Wu J., Dziadyk J.M., Zhu X., Sui M., and Fan W. Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells. Mol. Cancer Ther. 3 (2004) 271-277
33. Xu L., Chen S., and Bergan R.C. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene (2006)
34. Shin K.D., Lee M.Y., Shin D.S., Lee S., Son K.H., Koh S., Paik Y.K., Kwon B.M., and Han D.C. Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J. Biol. Chem. 280 (2005) 41439-41448